CIK 0000200406 · Large accelerated filer
JOHNSON & JOHNSON
Sign in to watch- Ticker
- JNJ
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Jan 3
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 221024240
- Phone
- 732-524-2455
- Business address
- ONE JOHNSON & JOHNSON PLZ, NEW BRUNSWICK, NJ, 08933
- Former names
- JOHNSON & JOHNSON ET AL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $16,898,386
- in 3 filings
Net −$16,898,386. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-13 | Wolk Joseph J Exec VP, CFO | Option exercise · Performance Share Units | −37,463 | 0 | ||
| 2026-02-13 | Wolk Joseph J Exec VP, CFO | Option exercise · Restricted Share Units | −1,779 | 0 | ||
| 2026-02-13 | Decker Robert J VP Corporate Controller | Option exercise | +312 | 21,313 | ||
| 2026-02-13 | Decker Robert J VP Corporate Controller | Shares withheld for taxes | −104 | $244.55 | $25K | 21,209 |
| 2026-02-13 | Decker Robert J VP Corporate Controller | Option exercise | +2,741 | 23,950 | ||
| 2026-02-13 | Decker Robert J VP Corporate Controller | Shares withheld for taxes | −762 | $244.55 | $186K | 23,188 |
| 2026-02-13 | Decker Robert J VP Corporate Controller | Option exercise · Restricted Share Units | −312 | 0 | ||
| 2026-02-13 | Decker Robert J VP Corporate Controller | Option exercise · Performance Share Units | −2,741 | 0 | ||
| 2026-02-13 | Forminard Elizabeth EVP, Chief Legal Officer | Option exercise | +651 | 16,199 | ||
| 2026-02-13 | Forminard Elizabeth EVP, Chief Legal Officer | Shares withheld for taxes | −314 | $244.55 | $77K | 15,885 |
| 2026-02-13 | Forminard Elizabeth EVP, Chief Legal Officer | Option exercise | +13,706 | 29,591 | ||
| 2026-02-13 | Forminard Elizabeth EVP, Chief Legal Officer | Shares withheld for taxes | −7,011 | $244.55 | $1.7M | 22,580 |
| 2026-02-13 | Forminard Elizabeth EVP, Chief Legal Officer | Option exercise · Restricted Share Units | −651 | 0 | ||
| 2026-02-13 | Forminard Elizabeth EVP, Chief Legal Officer | Option exercise · Performance Share Units | −13,706 | 0 | ||
| 2026-02-13 | Taubert Jennifer L EVP, WWC. Innovative Medicine | Option exercise | +1,302 | 179,315 | ||
| 2026-02-13 | Taubert Jennifer L EVP, WWC. Innovative Medicine | Shares withheld for taxes | −409 | $244.55 | $100K | 178,906 |
| 2026-02-13 | Taubert Jennifer L EVP, WWC. Innovative Medicine | Option exercise | +27,412 | 206,318 | ||
| 2026-02-13 | Taubert Jennifer L EVP, WWC. Innovative Medicine | Shares withheld for taxes | −13,547 | $244.55 | $3.3M | 192,771 |
| 2026-02-13 | Taubert Jennifer L EVP, WWC. Innovative Medicine | Option exercise · Restricted Share Units | −1,302 | 0 | ||
| 2026-02-13 | Taubert Jennifer L EVP, WWC. Innovative Medicine | Option exercise · Performance Share Units | −27,412 | 0 |
Page 11 of 19 · 365 trades